If you're not putting your patients first, someone else will. Yesterday, BBK hosted a webinar on patient centricity in clinical research. The webinar, Patient-centric to the Core: Setting a New Standard for Engagement Strategies in Clinical Research, addresses the topic of how patient centricity is no longer a nice-to-have; it is a critical component of any study's success.
Founded in 1983 with a $30,000 loan and two military surplus desks, BBK Worldwide has become a global, multi-million dollar corporation that is changing the face of patient recruitment for clinical R&D in the pharma and biopharma industries. Today, our founding principals, Bonnie A. Brescia and Joan F. Bachenheimer have created a global enterprise – one that that is true to their philosophies of how a business, its products, services, and culture can create new opportunities for its staff, clients and benefit consumers.
If you’re not putting your patients first, someone else will. Patient-centricity is no longer a nice-to-have; it is a critical component of any study’s success. Thoughtful and effective patient engagement and retention strategies should be employed throughout the entire clinical trial process – and the patient’s contribution to clinical research and the advancement of treatment options cannot be underestimated. Regardless of the inherent complexities of study management, clinical trial sponsors have an obligation to ensure patients have the best clinical trial experience possible.
Embracing the hustle and bustle as summer comes to a close, BBK will be leading sessions at three key industry events beginning with Patient-Centered Clinical Trials 2014, to be held at the Hyatt Regency Hotel in Boston, September 4-5. Patient recruitment experts Bonnie A. Brescia, Matthew Stumm, and Aaron Fleishman will share insights on the benefits of employing an effective patient engagement strategy, and how a variety of tactics - from media to mobile apps - can be used to drive study participation and overall trial success.
Utilizing social media in clinical research is a hot topic in the clinical R&D industry and many pharmaceutical companies are rightfully beginning to take note. According to a survey by the Pew Research Center, 85% of U.S. adults use the internet and 72% of those users say they have looked online for health information within the past year; however, The Tufts Center for the Study of Drug Development reports that only approximately 10% of trials reportedly use social media to recruit patients. Furthermore, BBK Worldwide research shows that pharmaceutical sponsors who use social media in their clinical trials are gaining a strong competitive advantage in terms of patient recruitment and retention.
Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study BuddySM Mobile Apps to Help Boost Patient Engagement
Mobile Apps to Streamline Valuable Resource and Information Sharing, Better Connect Advocacy Groups, Pharmaceutical Sponsors and Patients
DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study BuddySM and My Clinical Study BuddySM Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available today on iTunes® and the Google Play™ store and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
New R&D Model Protects Performance in a Threatened Enrollment Landscape
DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, the leader in patient recruitment, today unveiled a new specialty in clinical trial marketing: adaptive recruitment. Designed specifically to protect global enrollment integrity, within a changing or threatened landscape, adaptive recruitment helps sites and sponsors maximize tight budgets and timeframes by offering the tools and best-practices needed to ensure more informed recruitment and enrollment decisions – and the ability to seamlessly employ real-time corrections as needed. BBK Principal Matthew Stumm will discuss this new model in detail during his DIA Annual Meeting presentation, "Adopting New Strategies for the New Face of Patient Recruitment," on Tuesday, June 17 at 2:45 p.m. PST.
BBK Worldwide, the leader in patient recruitment, will lead three key talks at the DIA 2014 50th Annual Meeting, to be held at the San Diego Convention Center in San Diego, Calif., June 15-19. The company will also demo new products and mobile apps at booth #2309. Session details are as follows:
$100,000 to Be Awarded to Team with Most Novel Approach to Better Patient Health
BBK Worldwide Founding Principal Bonnie A. Brescia will serve as a judge in Sanofi US's "Partners in Patient Health" and North America R&D Hub Collaborate | Innovate Challenge at Sanofi US headquarters in New Jersey on Friday, May 9. The Challenge is designed to foster collaboration between non-profit organizations and academic institutions with a common purpose, and to promote sharing of complementary resources to propose new and novel approaches that translate patient insights into improvements in the drug development process. The winning team will receive $100,000 and have access to additional mentoring and guidance through Sanofi US.